Psilocybin for Grief and Bereavement: What the Research Shows
Grief is a universal human experience, but complicated grief — where normal grief becomes prolonged and debilitating — affects approximately 10% of bereaved people. Standard treatments (grief-focused CBT, antidepressants) have modest efficacy. Psilocybin has emerged as a promising option, particularly for people stuck in grief that isn't resolving.
Why Psilocybin May Help with Grief
Complicated grief shares neurological features with depression: hyperconnectivity in the default mode network (DMN), which generates ruminative thinking about the loss, and reduced cognitive flexibility that makes it hard to form new perspectives. Psilocybin's primary mechanism — disrupting DMN hyperconnectivity and creating neuroplasticity — directly addresses these features.
Clinically, psilocybin sessions often produce what researchers call "mystical experiences" — profound feelings of connectedness, meaning, and acceptance. These experiences appear to facilitate grief processing by enabling new perspectives on the loss and the deceased.
Clinical Evidence
A 2023 Johns Hopkins pilot study gave two psilocybin sessions (25mg) to 24 adults with complicated grief. At 6-month follow-up, participants showed significant reductions in grief severity, depression, and anxiety. 79% showed clinically meaningful improvement. These are preliminary results from a small study, but they're consistent with the broader psilocybin literature.
Microdosing for Grief
For people who cannot access supervised psilocybin therapy, microdosing offers a lower-intensity alternative. Microdosing doesn't produce the profound mystical experiences of macrodosing, but it does reduce the rumination and emotional rigidity that characterize complicated grief. Many users report that microdosing helps them "move through" grief rather than getting stuck in it.